This week at M2D2, Yunchao (Lance) Liu (刘运超) presented MolKGNN, an interpretable and chirality-aware GNN with improved performance for QSAR modeling The recording is now available here: youtu.be/P73oEikxI3Y

We are incredibly excited to integrate our powerful chemistry engine into Recursion’s OS to enable the future of AI-first drug discovery! We’ll be expanding our ML research team at Mila - Institut québécois d'IA with the aim of solving the hardest problems in drug discovery Stay tuned!

As part of our meetup at #ICML2023 on Wednesday, we’ll be hosting a panel with Cuong Nguyen (@gsk), Alan Cheng (@merck), @imranshaque (@recursionpharma), and Charlotte Bunne (@eth), moderated by Dan RSVP to secure your spot below: partiful.com/e/RQovXQfUfOAx…

Today we begin our new journey as Valence Labs: a semi-autonomous research engine within Recursion, dedicated to advancing the frontier of deep learning in #drugdiscovery. We’ve got a lot in store. A thread 🧵(1/5)

M2D2 is back! We’ll be joined by Prof. Amir Barati from Carnegie Mellon University who will discuss his recent work in large language molecular representation & learning. Join us live on Tuesday, October 17th at 11 am ET. Find more details here: portal.valencelabs.com/events/post/la…

Next week at M2D2, we’ll be joined by Hannes Stärk who will discuss his recent paper “Harmonic Self-Conditioned Flow Matching for Multi-Ligand Docking and Binding Site Design”. Join us live on Tuesday, Oct 24th at 11 AM ET. See more details here: portal.valencelabs.com/events/post/ha…

In the latest community blog, Jeff Guo from LIAC at EPFL describes how experience replay can accelerate generative molecular design. Read more here: portal.valencelabs.com/blogs/post/aug…

Introducing SAFE, Sequential Attachment-based Fragment Embedding, a novel molecular line notation that redefines molecular design tasks as simple autoregressive sequence generation. 🧵

Catch Emmanuel Noutahi Michael Craig Prudencio M Tossou Jonathan Lim at #NeurIPS tomorrow! They'll be presenting the SAFE paper at two workshops between 12:00 and 2:30 CST. See below for more details.👇

That’s a wrap on #NeurIPS 2023. From cohosting a 700+ person TechBio event with Recursion and @NVIDIA to showcasing our research, and more, this year was memorable! We are actively hiring. Come build the future of AI for drug discovery: valencelabs.com/careers

Introducing LOWE: an LLM-Orchestrated Workflow Engine for executing complex drug discovery workflows using natural language. The next evolution of the Recursion OS, LOWE has access to proprietary data, integrates with Recursion’s labs, and more 🧵 valencelabs.com/lowe

Next week at M2D2, Susana Vazquez Torres will present “De novo design of high-affinity binders of bioactive helical peptides” 📅 When: Tuesday from 11am - 12pm ET 📝 Read the paper: nature.com/articles/s4158… Tune in live: portal.valencelabs.com/events/post/de…

Tune in to the latest reading groups, read blogs, and connect with the TechBio community on Portal. We also provide weekly breakdowns of research, events, and talks in TechBio through our newsletter, Portal Weekly. Here’s a short recap of what we featured in the newsletter 🧵

Looking forward to this one!

To learn about the SOTA in batch effect removal in biochemical data, join us next Tuesday from 11am - 12pm ET.

Looking forward to #MoML2024 on June 19th! As always, tickets for students are FREE. Join us Mila - Institut québécois d'IA for an awesome day of speakers and poster presentations showcasing the latest research in molecular machine learning. Register here: portal.ml4dd.com/register

I am excited to present Polaris PyData London!✨ I look forward to share more about the benchmarking platform we are building Valence Labs and how this leverages zarr_dev as a universal data format. london2024.pydata.org/cfp/talk/Y3PTM…

Day 1 of the ML for Drug Discovery Summer School was awesome! 🏫 Over 150 people were in attendance to learn from speakers like Bharath Ramsundar, Emmanuel Noutahi, Dominique Beaini, and Mario Geiger. Topics covered included GNNs, virtual screening, molecular representation and scoring, and more.

Excited to welcome Anne Carpenter, PhD to Montreal to start week 2 of the ML for drug discovery summer school with an overview of phenomics in drug discovery!

1/ At Valence Labs, Recursion's AI research engine, we’re focused on advancing drug discovery outcomes through cutting-edge computational methods Today, we're excited to share our vision for building virtual cells, guided by the predict-explain-discover framework 🧵